Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Amortizatization of Intangibles (2022 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $148000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Amortizatization of Intangibles rose 5.71% year-over-year to $148000.0, compared with a TTM value of $589000.0 through Dec 2023, up 7.48%, and an annual FY2024 reading of $577000.0, down 2.04% over the prior year.
  • Amortizatization of Intangibles was $148000.0 for Q4 2023 at Terns Pharmaceuticals, down from $150000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $150000.0 in Q3 2023 and bottomed at $131000.0 in Q2 2022.